Literature DB >> 22129351

Dihydroxybenzoic acid isomers differentially dissociate soluble biotinyl-Aβ(1-42) oligomers.

Harry LeVine1, Levi Lampe, Lina Abdelmoti, Corinne E Augelli-Szafran.   

Abstract

Polyphenolic compounds including a number of natural products such as resveratrol, curcumin, catechin derivatives, and nordihydroguaiaretic acid have effects on the assembly of Aβ fibrils and oligomers as well as on fibril morphology. Based on a lead structure obtained from a screen of a small molecule diversity library, simple benzoic acid derivatives distinguished by the number and position of hydroxyls on the aromatic ring displayed different abilities to dissociate preformed biotinyl-Aβ(1-42) oligomers. The 2,3-, 2,5-, and 3,4-dihydroxybenzoic acid (DHBA) isomers were active oligomer dissociators. The remaining DHBA isomers and the monohydroxy and unsubstituted benzoic acids were inactive and did not compete with the active compounds to block oligomer dissociation. None of the compounds blocked oligomer assembly, indicating that they do not interact with monomeric Aβ to shift the oligomer-monomer equilibrium. Dissociating activity was not associated with quinone redox cycling capacity of the compounds. Gallic acid (3,4,5-trihydroxybenzoic acid) stabilized biotinyl-Aβ(1-42) oligomers against intrinsic dissociation and blocked the effects of the active dissociators, independent of the concentration of dissociator. A model for the mechanism of action of the DHBA dissociators proposes that these compounds destabilize oligomer structure promoting progressive monomer dissociation rather than fissioning oligomers into smaller, but still macromolecular, species. Gallic acid blocks dissociation by stabilizing oligomers against this process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22129351      PMCID: PMC4006955          DOI: 10.1021/bi201288x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

1.  Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation.

Authors:  Dominic M Walsh; Matthew Townsend; Marcia B Podlisny; Ganesh M Shankar; Julia V Fadeeva; Omar El Agnaf; Dean M Hartley; Dennis J Selkoe
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

2.  Biotin-avidin interaction-based screening assay for Alzheimer's beta-peptide oligomer inhibitors.

Authors:  Harry LeVine
Journal:  Anal Biochem       Date:  2006-05-11       Impact factor: 3.365

3.  Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways.

Authors:  Ali Reza A Ladiwala; Jonathan S Dordick; Peter M Tessier
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

4.  Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.

Authors:  Mihaela Necula; Rakez Kayed; Saskia Milton; Charles G Glabe
Journal:  J Biol Chem       Date:  2007-02-06       Impact factor: 5.157

5.  Clioquinol and other hydroxyquinoline derivatives inhibit Abeta(1-42) oligomer assembly.

Authors:  Harry LeVine; Qunxing Ding; John A Walker; Randal S Voss; Corinne E Augelli-Szafran
Journal:  Neurosci Lett       Date:  2009-08-05       Impact factor: 3.046

Review 6.  Alzheimer's disease amyloid beta-protein and synaptic function.

Authors:  Tomas Ondrejcak; Igor Klyubin; Neng-Wei Hu; Andrew E Barry; William K Cullen; Michael J Rowan
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

7.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

8.  EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity.

Authors:  Jan Bieschke; Jenny Russ; Ralf P Friedrich; Dagmar E Ehrnhoefer; Heike Wobst; Katja Neugebauer; Erich E Wanker
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

Review 9.  Discovery of ADDL--targeting small molecule drugs for Alzheimer's disease.

Authors:  Gary C Look; Jasna Jerecic; Diana B Cherbavaz; Todd R Pray; Jean-Claude R Breach; Walter J Crosier; Lev Igoudin; Catherine M Hironaka; Raymond M Lowe; Michele McEntee; Lily Ruslim-Litrus; Hsiu-Mei Wu; Sue Zhang; Susan M Catalano; William F Goure; David Summa; Grant A Krafft
Journal:  Curr Alzheimer Res       Date:  2007-12       Impact factor: 3.498

10.  Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts.

Authors:  Fiorella Malchiodi-Albedi; Silvia Paradisi; Andrea Matteucci; Claudio Frank; Marco Diociaiuti
Journal:  Int J Alzheimers Dis       Date:  2011-02-08
View more
  5 in total

1.  Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues.

Authors:  Mizuho Sato; Kazuma Murakami; Mayumi Uno; Yu Nakagawa; Sumie Katayama; Ken-ichi Akagi; Yuichi Masuda; Kiyonori Takegoshi; Kazuhiro Irie
Journal:  J Biol Chem       Date:  2013-06-21       Impact factor: 5.157

2.  Anti-amyloidogenic properties of some phenolic compounds.

Authors:  Afsaneh Porzoor; Benjamin Alford; Helmut M Hügel; Danilla Grando; Joanne Caine; Ian Macreadie
Journal:  Biomolecules       Date:  2015-04-17

3.  Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity.

Authors:  Mustafa T Ardah; Katerina E Paleologou; Guohua Lv; Salema B Abul Khair; Abdulla S Kazim; Saeed T Minhas; Taleb H Al-Tel; Abdulmonem A Al-Hayani; Mohammed E Haque; David Eliezer; Omar M A El-Agnaf
Journal:  Front Aging Neurosci       Date:  2014-08-05       Impact factor: 5.750

Review 4.  Polyphenols with Anti-Amyloid β Aggregation Show Potential Risk of Toxicity Via Pro-Oxidant Properties.

Authors:  Hatasu Kobayashi; Mariko Murata; Shosuke Kawanishi; Shinji Oikawa
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

5.  Combining Chalcones with Donepezil to Inhibit Both Cholinesterases and Aβ Fibril Assembly.

Authors:  Nishad Thamban Chandrika; Marina Y Fosso; Oleg V Tsodikov; Harry LeVine Iii; Sylvie Garneau-Tsodikova
Journal:  Molecules       Date:  2019-12-24       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.